Inmune Bio, Inc. - COM (INMB)

Historical Portfolio Holders from Q1 2019 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
5.35M
Holdings value Q3 2024
$28.8M
Value change Q3 2024
+$6.02M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
64
Number of buys Q3 2024
42
Number of sells Q3 2024
-14
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 5.35M $28.8M +$6.02M $5.39 65
2024 Q2 4.57M $40.3M +$15.4M $8.82 56
2024 Q1 2.74M $32.2M +$5.31M $11.75 50
2023 Q4 2.29M $25.8M +$1.85M $11.26 46
2023 Q3 2.13M $14.5M -$5.89M $6.77 36
2023 Q2 2.19M $24.8M +$8.53M $9.08 32
2023 Q1 1.8M $11.7M +$1.1M $6.46 32
2022 Q4 1.65M $10.4M -$728K $6.34 31
2022 Q3 1.91M $11.9M -$744K $6.20 31
2022 Q2 2.01M $17.6M -$2.41M $8.84 34
2022 Q1 2.29M $19.3M -$2.11M $8.42 31
2021 Q4 2.48M $25.3M +$4.76M $10.20 41
2021 Q3 1.94M $37.7M +$4.89M $19.42 40
2021 Q2 1.71M $30M +$8.04M $17.57 38
2021 Q1 1.31M $15.5M +$5.45M $11.88 31
2020 Q4 792K $13.6M +$1.19M $17.21 24
2020 Q3 992K $10.2M +$6.46M $10.30 26
2020 Q2 359K $1.88M +$105K $5.17 11
2020 Q1 342K $1.14M +$201K $3.32 9
2019 Q4 282K $1.64M +$40.4K $5.80 9
2019 Q3 275K $1.62M +$1.39M $5.90 9
2019 Q2 38.5K $373K -$44K $9.72 7
2019 Q1 45.1K $352K +$352K $7.44 5